Try our beta test site
1 study found for:    Open Studies | lymphoma OR CLL | AGS67E
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies
Conditions: Relapsed Lymphoid Malignancy;   Refractory Lymphoid Malignancy
Intervention: Drug: AGS67E

Study has passed its completion date and status has not been verified in more than two years.